Gil Kerlikowske, Director of ONDCP, to Speak on the National Drug Plan to Combat Prescription Drug Abuse at the NABP 108th Annual Meeting
The National Association of Boards of Pharmacy® (NABP®) is pleased to welcome Gil Kerlikowske, director of the Office of National Drug Control Policy (ONDCP) as a speaker at its 108th Annual Meeting. Kerlikowske will discuss how the prescription drug abuse epidemic is affecting the people of the United States and what the federal government is […]
Read More ›Federal Legislation Takes Aim at Prescription Counterfeits, Illegal Internet Drug Distribution
Originally published in the April 2012 NABP Newsletter In 2011, counterfeit pharmaceuticals made up the largest portion of seized items in the Consumer Safety and Technology category, at 28% when ranked by domestic value, as reported by United States Customs and Border Protection. Through its own research, NABP has identified 3,845 Web sites selling drugs […]
Read More ›NABP Urges ICANN to Take Action to Protect Public Health From Domain Registrars Enabling Rogue Online Pharmacies
LegitScript Investigation Finds Registrar Facilitating Fake Pharmacies’ Unlawful Activities The National Association of Boards of Pharmacy® (NABP®) has contacted the Internet Corporation for Assigned Names and Numbers (ICANN) urging the organization to take action against Internet.bs, a Web site registrar that has been found to be responsible for 44% of the Web sites that NABP […]
Read More ›Center for Pharmacy Practice Accreditation Established by NABP and APhA
The Center for Pharmacy Practice Accreditation (CPPA), a partnership between NABP and the American Pharmacists Association (APhA), has been established to develop and implement comprehensive programs of pharmacy practice site accreditation. CPPA is responsible for developing, maintaining, and ensuring proper implementation of consensus-based accreditation standards for pharmacy practice sites, and the organization’s goal is to […]
Read More ›PSM LEADER’s Guide Offers Tips for Protecting Patients from Counterfeits
The Partnership for Safe Medicines has released a guide to assist health care providers in protecting patients from counterfeit drugs and recognizing the signs that may indicate use of counterfeits. Three versions of the LEADER’s Guide – one for nurses, one for doctors, and another specific to pharmacists – are available for download from the […]
Read More ›Federal Bill Would Prevent State Inspections of Drugs and Devices if FDA Required Inspections Completed
Representative Brian Bilbray (R-CA) introduced a bill to the US House that would prevent states from requiring inspections of drug or device manufacturers, packagers, or distributors that are duplicative to inspections required by FDA. The Science and Technology Regulatory Relief Act of 2012 (HR 4056) would amend the Federal Food, Drug, and Cosmetic Act to […]
Read More ›Suspect Online Sellers Offer Drugs in Shortage, Place Patients at Risk, Study Concludes
Of 72 drugs identified in shortage by FDA as of September 2011, 68, or 94%, were offered for sale online, primarily by sites on the NABP Not Recommended list, according to a new study. To determine the potential for patient safety risks related to Web sites selling shortage drugs, researchers assessed the prevalence and characteristics […]
Read More ›NABP Supports Legislation Aimed to Protect Patients from Counterfeit Drugs and Fake Online Pharmacies
Association Issues Statement of Support for Online Pharmacy Safety Act of 2011 The National Association of Boards of Pharmacy® (NABP®) has documented thousands of fake online pharmacies that endanger the lives of unsuspecting American consumers by distributing counterfeit, adulterated, and substandard drug products, often without requiring a valid prescription. By implementing safeguards, such as a […]
Read More ›Oxycodone Purchases in Florida Show Steady Decline Due to New Laws, DEA Reports
Drug Enforcement Administration (DEA) data illustrates a 97% decrease in oxycodone purchases by doctors in Florida from 2010 to 2011, following the implementation of new state laws in 2011. DEA notes that in 2010 Automation of Reports and Consolidated Orders System (ARCOS) data showed that 90 of the top 100 oxycodone purchasing physicians in the […]
Read More ›PSM Honors NABP with Guardian Award for Efforts to Fight Counterfeit Medicines
Originally published in the February 2012 NABP Newsletter. The Partnership for Safe Medicines (PSM) presented NABP with the inaugural Guardian award, recognizing the Association’s efforts in raising awareness of and combating unlicensed online pharmacies. The award was presented at the PSM Interchange, October 27, 2011, an annual conference bringing together investigators, regulators, patient advocates, counterfeit […]
Read More ›